Page last updated: 2024-12-11

aminoethoxyvinylglycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aminoethoxyvinylglycine: RN given for (S-(E))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6436272
CHEMBL ID1619821
SCHEMBL ID167462
SCHEMBL ID2263373
MeSH IDM0233293

Synonyms (35)

Synonym
49669-74-1
l-2-amino-4-(2-aminoethoxy)-trans-3-butenoic acid
ro 4468
(s-(e))-2-amino-4-(2-aminoethoxy)-3-butenoic acid
3-butenoic acid, 2-amino-4-(aminoethoxy)-, (2s,3e)-
l-2-amino-4-(2'-aminoethoxy)-trans-3-butenoic acid
3-butenoic acid, 3-amino-4-(2-aminoethoxy)-, (s-(e))-
nsc 234613
aminoethoxyvinylglycine
einecs 256-423-8
aviglycine
l-trans-2-amino-4-(2-aminoethoxy)-3-butenoic acid
373355D7-AD17-4291-976E-6E2FC86BA873
(s)-trans-2-amino-4-(2-aminoethoxy)-3-butenoic acid
chembl1619821 ,
bdbm50280040
(e,2s)-2-amino-4-(2-aminoethoxy)but-3-enoic acid
ow5h814y1i ,
unii-ow5h814y1i
aviglycine [iso]
3-butenoic acid, 2-amino-4-(2-aminoethoxy)-, (s-(e))-
ro-4468
aminoethoxyvinylglycine [mi]
3-butenoic acid, 2-amino-4-(2-aminoethoxy)-, (2s,3e)-
gtpl8860
SCHEMBL167462
DTXSID7043875
SCHEMBL2263373
[s-(e)]-2-amino-4-(2-aminoethoxy)-3-butenoic acid
Q27074449
(s,e)-2-amino-4-(2-aminoethoxy)but-3-enoic acid
HY-119646
STARBLD0008673
CS-0077199
AKOS040746598

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Aminoethoxyvinylglycine (AVG)-treated, ethylene-nonproducing N."( Ethylene sensing and gene activation in Botrytis cinerea: a missing link in ethylene regulation of fungus-plant interactions?
Chagué, V; Danit, LV; Schulze-Gronover, C; Sharon, A; Siewers, V; Tudzynski, B; Tudzynski, P, 2006
)
1.06
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
Ethylene signaling pathway03

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cystathionine gamma-lyaseHomo sapiens (human)IC50 (µMol)1.10000.57002.86098.0000AID1504913
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (14)

Processvia Protein(s)Taxonomy
cysteine metabolic processCystathionine gamma-lyaseHomo sapiens (human)
lipid metabolic processCystathionine gamma-lyaseHomo sapiens (human)
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysineCystathionine gamma-lyaseHomo sapiens (human)
cysteine biosynthetic process via cystathionineCystathionine gamma-lyaseHomo sapiens (human)
cysteine biosynthetic processCystathionine gamma-lyaseHomo sapiens (human)
transsulfurationCystathionine gamma-lyaseHomo sapiens (human)
endoplasmic reticulum unfolded protein responseCystathionine gamma-lyaseHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionCystathionine gamma-lyaseHomo sapiens (human)
protein sulfhydrationCystathionine gamma-lyaseHomo sapiens (human)
protein homotetramerizationCystathionine gamma-lyaseHomo sapiens (human)
hydrogen sulfide biosynthetic processCystathionine gamma-lyaseHomo sapiens (human)
positive regulation of aortic smooth muscle cell differentiationCystathionine gamma-lyaseHomo sapiens (human)
cellular response to leukemia inhibitory factorCystathionine gamma-lyaseHomo sapiens (human)
negative regulation of apoptotic signaling pathwayCystathionine gamma-lyaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (9)

Processvia Protein(s)Taxonomy
cystathionine gamma-lyase activityCystathionine gamma-lyaseHomo sapiens (human)
protein bindingCystathionine gamma-lyaseHomo sapiens (human)
calmodulin bindingCystathionine gamma-lyaseHomo sapiens (human)
pyridoxal phosphate bindingCystathionine gamma-lyaseHomo sapiens (human)
identical protein bindingCystathionine gamma-lyaseHomo sapiens (human)
L-cystine L-cysteine-lyase (deaminating)Cystathionine gamma-lyaseHomo sapiens (human)
homocysteine desulfhydrase activityCystathionine gamma-lyaseHomo sapiens (human)
L-cysteine desulfhydrase activityCystathionine gamma-lyaseHomo sapiens (human)
selenocystathionine gamma-lyase activityCystathionine gamma-lyaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
cytosolCystathionine gamma-lyaseHomo sapiens (human)
extracellular exosomeCystathionine gamma-lyaseHomo sapiens (human)
cytoplasmCystathionine gamma-lyaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1504913Inhibition of cystathionine gamma-lyase (unknown origin)2017ACS medicinal chemistry letters, Dec-14, Volume: 8, Issue:12
2-Arylidene Hydrazinecarbodithioates as Potent, Selective Inhibitors of Cystathionine γ-Lyase (CSE).
AID1345185Human Cystathionine gamma-lyase (Hydrogen sulphide synthesis)2013British journal of pharmacology, Jun, Volume: 169, Issue:4
Selectivity of commonly used pharmacological inhibitors for cystathionine β synthase (CBS) and cystathionine γ lyase (CSE).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (90)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (6.67)18.7374
1990's7 (7.78)18.2507
2000's42 (46.67)29.6817
2010's33 (36.67)24.3611
2020's2 (2.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.83 (24.57)
Research Supply Index4.53 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index43.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other92 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]